25 February 2021
Biorelate signs multi-year deal with e-therapeutics
Biorelate has announced a new 3 year contract with e-therapeutics PLC for Galactic Data. After 2 successful years of collaboration, Biorelate will continue to provide auto-curated cause-and-effect data to fuel e-therapeutics’ data-driven discovery platform. Jonny Wray (CTO...
24 February 2021
Cytox launches genoSCORE-LAB test to predict the risk of developing Alzheimer’s disease
Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to Alzheimer’s from a simple saliva sample provided from home … Test can guide lifestyle interventions to potentially slow disease progression … 24th February 2021:
16 February 2021
The pill could be sold in pharmacies without prescription
Some contraceptive pills could be sold over the counter in the UK for the first time, the government has said. It is asking the public for their views on whether two progestogen-only pills, also known as the "mini-pill", should be available without prescription. The move has...
11 February 2021
Maxwellia spearheading shift to self-care with three pharmacy products in launch pipeline
Push to convert more prescription medicines to over-the-counter will put pharmacists at heart of nation's public health, helping futureproof NHS … LONDON, Feb. 11, 2021 - Pioneering pharma company Maxwellia is poised to transform the UK's self-care market by giving people easier...
11 February 2021
Maxwellia announces appointment of Tim Holmes as Head of Sales
Maxwellia, the UK’s only dedicated expert medicines switching company, has appointed Tim Holmes to the newly created role of Head of Sales with responsibility for building the company’s customer strategy and customer success model. The appointment is the second so...
2 February 2021
AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence
Liege, Februray, 02, 2021 – Belgium-based AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with Pill Connect Ltd, an English company specializing in the design, development and manufacture of innovative medical...
1 February 2021
Blueberry Therapeutics announces extension of its Series B round with investment from Medical Incubator Japan and US Dermatology Syndicate
Blueberry Therapeutics Limited would like to announce that it has completed a £3.6m extension to the previously successful Series B Fundraising of £10.8m. This investment is from a Japanese investor, Medical Incubator Japan (MIJ) and a private syndicate of US Board...
28 January 2021
Chris Hall elected chairman of Pill Connect
MANCHESTER, U.K. — Pill Connect, formerly known as Elucid mHealth, has elected Chris Hall chairman of the company. Pill Connect is a world leader in medicine adherence monitoring and data capture on patient compliance. This follows the recent successful funding raise...
27 January 2021
Panthera continues to sign up new clinical trials across its UK network of dedicated clinical trial sites
Panthera continues to sign up new contracts despite COVID -19. Unlike many other clinical trial sites, Panthera’s dedicated sites do not mix clinical trial patients with other patients minimizing the risk of COVID -19 infection for both patients and staff. Many research...
21 January 2021
Manchester Imaging teams up with Michelson Diagnostics
Michelson Diagnostics Ltd, manufacturer of the world-leading VivoSight™ OCT skin imaging and measurement system, has teamed up with AI specialists Manchester Imaging Ltd, to aid dermatologists in the fight against skin cancer and other skin diseases. Michelson’s...